Unilab Inc., the country’s leading pharmaceutical and health care company, lauded the Food and Drug Administration (FDA) for taking proactive measures to protect the public from fake medicines.
Unilab said in a statement it is committed to continue working closely with the FDA and other concerned government agencies and civic groups in ridding the market of counterfeit drugs.
“Through the years, we have continuously collaborated with the FDA, the National Bureau of Investigation and Intellectual Property Office, to prevent the perpetration of this criminal act. We remain committed to working with the government and non-government organizations in protecting the welfare of Filipinos,” the company said.
The FDA issued an advisory on May 31 to warn the public that counterfeit versions of six popular and highly trusted over-the-counter medicines of Unilab were proliferating in the market. “We commend the leadership of the FDA, led by director-general Dr. Samuel Zacate, for releasing an urgent public advisory indicating their concern over the proliferation of counterfeit medicines being perpetuated by unscrupulous groups who exploit and take advantage of the trust and confidence of the public on their trusted Unilab brands,” it said.
